BDSI - Upcoming BUNAVAIL NDA submission mid-summer, and Phase 3 BEMA Buprenorphine results due 4Q13.
RMTI - Phase 3 CRUISE 1 significantly met endpoints, and Phase 3 CRUISE 2 results due October 2013.
Sentiment: Strong Buy
I have RMTI, so I concur. BDSI has a competitor just recently approved, not sure how well that one will play out long term.